Juvenile Dermatomyositis: Clinical Trials

4 trials for Juvenile Dermatomyositis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 2
Phase 11Recruiting 1
Phase 31Recruiting 1

Follow Juvenile Dermatomyositis: new trials by email Literature Review of Juvenile Dermatomyositis trials Research Report on Juvenile Dermatomyositis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Descartes-08 - Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)
Phase 1 / Phase 2RecruitingCartesian Therapeutics502026-01-142026-07-27
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
CABA-201 following preconditioning with fludarabine and cyclophosphamide - Idiopathic Inflammatory Myopathy, Dermatomyositis
Phase 2 / Phase 3RecruitingCabaletta Bio742023-12-202026-11-13
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
Baricitinib, pharmacokinetics study, dosage of cytokines - Juvenile Dermatomyositis
Phase 2CompletedAssistance Publique - Hôpitaux de Paris162022-11-102026-04-23
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Rituximab, Placebo - Myositis, Dermatomyositis
Phase 2CompletedUniversity of Pittsburgh2002006-03-012015-03-04

Narrower conditions

Dermatomyositis (4)  ·  Myositis (2)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Autoimmune Diseases (1)  ·  Polymyositis (1)

Broader conditions

Connective Tissue Diseases (4)  ·  Muscular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Nervous System Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Polymyositis (3)  ·  Immune System Diseases (2)  ·  Myositis (2)  ·  Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Systemic Vasculitis (1)  ·  Vascular Diseases (1)

Interventions

Cyclophosphamide (1)  ·  Pregnancy Tests (1)  ·  Rituximab (1)  ·  baricitinib (1)  ·  fludarabine (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Cabaletta Bio (1)  ·  Cartesian Therapeutics (1)  ·  University of Pittsburgh (1)

Countries

United States (3)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Ann M. Reed, MD (1)  ·  Chester V. Oddis, MD (1)

Results publications

PMID 23124935, PMID 39245937

NIH funding

R01AR061298 (1)